SLGL

Sol-Gel Technologies Ltd. Ordinary Shares

55.12

USD

-1.13

-2.01%

Nov 13, 15:59 UTC -5

Closed

After-Market

70.06

+14.95

+27.11%

Sol-Gel Technologies Ltd. Ordinary Shares (SLGL) Earnings

SLGL Earnings Reports

Positive Surprise Ratio

SLGL beat 24 of 33 last estimates.

73%

Next Report

Date of Next Report

Mar 17, 2027

Estimate for Q4 26 (Revenue/ EPS)

$178.50K

-$2.08

Implied change from Q3 26 (Revenue/ EPS)

+335.37%

+20.93%

Implied change from Q4 25 (Revenue/ EPS)

-74.35%

+94.39%

Sol-Gel Technologies Ltd. Ordinary Shares earnings per share and revenue

On Nov 12, 2026, SLGL reported earnings of -1.72 USD per share (EPS) for Q3 26, beating the estimate of -2.11 USD, resulting in a 18.67% surprise. Revenue reached 41.00 thousand, compared to an expected 153.00 thousand, with a -73.20% difference. The market reacted with a -11.28% price change (close before vs. close after earnings).

Looking ahead to Q4 26, -- analysts forecast an EPS of -2.08 USD, with revenue projected to reach 178.50 thousand USD, implying an increase of 20.93% EPS, and increase of 335.37% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Personalis, Inc. Common Stock

Report Date

Nov 04, 2026 For Q3 26

Estimate

-$0.25

Actual

-$0.32

Surprise

-24.08%

Taysha Gene Therapies, Inc. Common Stock

Report Date

Nov 12, 2026 For Q3 26

Estimate

-$0.13

Actual

-$0.10

Surprise

+24.59%

Amphastar Pharmaceuticals, Inc.

Report Date

Nov 05, 2026 For Q3 26

Estimate

$0.87

Actual

$1.13

Surprise

+30.18%

Teva Pharmaceutical Industries Limited

Report Date

Nov 03, 2026 For Q3 26

Estimate

$0.74

Actual

$0.86

Surprise

+15.50%

Metagenomi Therapeutics, Inc. Common Stock

Report Date

Nov 10, 2026 For Q3 26

Estimate

-$0.64

Actual

-$0.56

Surprise

+13.31%

FAQ

What were Sol-Gel Technologies Ltd. Ordinary Shares's earnings and revenue for the latest quarter Q3 2026?

For Q3 2026, Sol-Gel Technologies Ltd. Ordinary Shares reported EPS of -$1.72, beating estimates by 18.67%, and revenue of $41.00K, -73.2% below expectations.

How did the market react to Sol-Gel Technologies Ltd. Ordinary Shares's Q3 2026 earnings?

The stock price moved down -11.28%, changed from $63.40 before the earnings release to $56.25 the day after.

When is Sol-Gel Technologies Ltd. Ordinary Shares expected to report next?

The next earning report is scheduled for Mar 17, 2027.

What are the forecasts for Sol-Gel Technologies Ltd. Ordinary Shares's next earnings report?

Based on -- analysts, Sol-Gel Technologies Ltd. Ordinary Shares is expected to report EPS of -$2.08 and revenue of $178.50K for Q4 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.